✦ LIBER ✦
392 POSTER A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib
✍ Scribed by J.C. Soria; E. Felip; R. Herbst; N. Hannah; S. laurie; J.P. Armand; F. Shepherd; D. Berman
- Book ID
- 119599548
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 63 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.